Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation.
- Published in:
- AAPS Journal, 2019, v. 21, n. 6, p. 1, doi. 10.1208/s12248-019-0378-y
- By:
- Publication type:
- Article
Works matching IS 15507416 AND DT 2019 AND VI 21 AND IP 6
Results: 8
1
2
Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib.
- Published in:
- AAPS Journal, 2019, v. 21, n. 6, p. 1, doi. 10.1208/s12248-019-0374-2
- By:
- Publication type:
- Article
3
Retrospective Analysis of Bioanalytical Method Validation Approaches in Biosimilar Biological Product Development.
- Published in:
- AAPS Journal, 2019, v. 21, n. 6, p. 1, doi. 10.1208/s12248-019-0376-0
- By:
- Publication type:
- Article
4
Fit-for-Purpose Quality Control System in Continuous Bioanalysis During Long-Term Pediatric Studies.
- Published in:
- AAPS Journal, 2019, v. 21, n. 6, p. 1, doi. 10.1208/s12248-019-0375-1
- By:
- Publication type:
- Article
5
Optimization of Cancer Treatment in the Frequency Domain.
- Published in:
- AAPS Journal, 2019, v. 21, n. 6, p. 1, doi. 10.1208/s12248-019-0372-4
- By:
- Publication type:
- Article
6
How Transporters Have Changed Basic Pharmacokinetic Understanding.
- Published in:
- AAPS Journal, 2019, v. 21, n. 6, p. 1, doi. 10.1208/s12248-019-0373-3
- By:
- Publication type:
- Article
7
On the Comparison of Methods in Analyzing Bounded Outcome Score Data.
- Published in:
- AAPS Journal, 2019, v. 21, n. 6, p. N.PAG, doi. 10.1208/s12248-019-0370-6
- By:
- Publication type:
- Article
8
Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay.
- Published in:
- AAPS Journal, 2019, v. 21, n. 6, p. N.PAG, doi. 10.1208/s12248-019-0369-z
- By:
- Publication type:
- Article